| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 5,335,750 | 4,230,045 | 3,026,139 | | Cost of Revenue | 1,127,246 | 768,771 | 433,320 | | | Gross Profit | 4,208,504 | 3,461,274 | 2,592,819 | | | Operating Expenses | | Research Development | 721,768 | 591,026 | 383,861 | | Selling General and Administrative | 797,344 | 705,741 | 573,660 | | Non Recurring | 10,851 |
-
| 2,394,051 | | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 2,678,541 | 2,164,507 | (758,753) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 59,401 | 109,823 | 134,642 | | Earnings Before Interest And Taxes | 2,746,506 | 2,283,438 | (617,845) | | Interest Expense | 12,101 | 13,100 | 20,362 | | Income Before Tax | 2,734,405 | 2,270,338 | (638,207) | | Income Tax Expense | 723,251 | 655,040 | 551,750 | | Minority Interest | 8,564 | 9,108 | 6,266 | | | | Net Income From Continuing Ops | 2,011,154 | 1,615,298 | (1,189,957) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 2,011,154 | 1,615,298 | (1,189,957) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $2,011,154 | $1,615,298 | ($1,189,957) |
|
0.13% Nasdaq 
Income Statement
